Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ureteral Stent Length and Patient Symptoms

This study has been terminated.
(Because no staff to consent or enroll subjects)
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University Identifier:
First received: February 6, 2006
Last updated: December 23, 2013
Last verified: December 2013

The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.

Condition Intervention
Kidney Stones
Device: Ureteral Stent

Study Type: Observational
Study Design: Time Perspective: Prospective

Further study details as provided by Emory University:

Enrollment: 1
Study Start Date: February 2006
Study Completion Date: October 2006
Intervention Details:
    Device: Ureteral Stent
    Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Detailed Description:

Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones


Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -

Exclusion Criteria:Under 18 years of age, inability to give informed consent


  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00288457

Sponsors and Collaborators
Emory University
Principal Investigator: John G Pattaras, MD Emory University
  More Information

No publications provided

Responsible Party: John G Pattaras, MD, Associate Professor, Emory University Identifier: NCT00288457     History of Changes
Other Study ID Numbers: 0758-2003
Study First Received: February 6, 2006
Last Updated: December 23, 2013
Health Authority: United States: Food and Drug Administration processed this record on March 01, 2015